SecBot SecBot
PRE-MARKET · TUE · NOV 10 · 2026 · 07:49 ET ·REGIMEELEVATED

Post-election recovery meets AI reckoning, markets stage best day since April as NVDA scandal deepens, with October CPI the next macro test

SecBot Research
01Executive Summary
  • U.S. equities surged Monday in the broadest rally since April, with the S&P 500 gaining +2.35% to 7,549.94 and the Nasdaq +2.74%, as markets rebounded from last week's post-election AI rout.
  • Nvidia (NVDA) bucked the rally, falling -4.27% as the CEO spy-scandal investigation deepened, the board launched an independent probe and Jensen Huang admitted to an affair with an alleged Chinese intelligence asset.
  • October CPI prints at 8:30 AM ET today, the week's marquee macro release, with Fed rate expectations (currently 3.75–4.00%) and the post-election policy outlook both in focus.
  • European and Asian markets are higher overnight, Euro Stoxx 50 +1.07%, Nikkei +2.87%, extending the global risk-on tone.
  • Oil (-1.84%) and gold (-0.77%) are softer in pre-market trading as the dollar firms modestly (DXY 101.76).
02Market Snapshot
S&P 500
7,549.94
▲ +2.35% +173.08
30D -3.35%
Nasdaq
25,253.14
▲ +2.74% +673.71
30D -7.72%
Dow Jones
52,389.75
▲ +2.15% +1,104.02
30D +1.42%
Russell 2000
2,840.81
▲ +3.15% +86.70
30D +1.21%
VIX
19.92
▼ -22.31% -5.72
30D +34.23%
03Sector & Breadth
Leaders
Industrials (XLI)
+3.82%
Technology (XLK)
+3.73%
Consumer Discretionary (XLY)
+2.92%
Communication Services (XLC)
+2.45%
Health Care (XLV)
+1.91%
Laggards
Energy (XLE)
+0.52%
Consumer Staples (XLP)
+0.90%
Financials (XLF)
+1.45%
Real Estate (XLRE)
+1.45%
Utilities (XLU)
+1.53%
04ETF Flows
Inflows
SPY SPDR S&P 500 ETF Trust
+$5.14B
QQQ Invesco QQQ Trust
+$3.94B
SOXX iShares Semiconductor ETF
+$1.01B
IEF iShares 7-10 Year Treasury Bond ETF
+$669.4M
TLT iShares 20+ Year Treasury Bond ETF
+$409.0M
Outflows
IGV iShares Expanded Tech-Software ETF
-$396.5M
XLF Financial Select Sector SPDR
-$370.2M
DIA SPDR Dow Jones Industrial Average ETF
-$258.5M
COPX Global X Copper Miners ETF
-$237.8M
XLY Consumer Discretionary Select SPDR
-$184.6M
05Biggest Movers
Gainers
AMD ▲ +13.26%
Advanced Micro Devices
Rotation beneficiary as traders flee NVDA on CEO scandal; +13% best single-day gain in months
TSLA ▲ +5.54%
Tesla Inc.
Broad tech rebound; post-election policy clarity lifting growth names
INTC ▲ +5.49%
Intel Corp.
AI chip rotation play; value bid into semiconductor weakness
META ▲ +5.12%
Meta Platforms
Risk-on rally; mega-cap tech bounces from post-election selloff
Losers
NVDA ▼ -4.27%
Nvidia Corp.
CEO spy-scandal investigation deepens; board launches independent probe, Huang admits affair
BA ▼ -0.59%
Boeing Co.
Mildly lower in broad industrials strength; company-specific headwinds persist
06Key Drivers
  1. 01 October CPI report due at 8:30 AM ET, the week's most important macro release, with Fed rate expectations (currently 3.75–4.00%) on the line.
  2. 02 Nvidia CEO Jensen Huang admitted to an affair with an alleged Chinese intelligence asset; the board launched an independent investigation and the FBI is probing. NVDA -4.27% yesterday, -1.04% pre-market.
  3. 03 Midterm election results (Democratic Congress) triggered a severe AI/tech selloff on Nov 5; markets are now in recovery mode with the S&P 500 erasing 85% of last week's loss.
  4. 04 Bettors now see a 55% probability Jensen Huang is out as NVDA CEO before 2029, per prediction markets.
  5. 05 Wells Fargo lowered NVDA price target from $315 to $300 this morning; RBC and Goldman reiterated Outperform/Buy with targets of $330 and $300 respectively.
  6. 06 European equities rallying (Euro Stoxx 50 +1.07%) and Nikkei surging +2.87% overnight, extending the global risk-on tone.
  7. 07 Oil (-1.84%) under pressure as demand concerns resurface; gold (-0.77%) easing from recent highs.
  8. 08 SPY saw $5.14B in inflows and QQQ $3.94B, the largest single-day ETF inflows in weeks, signaling institutional dip-buying.
07Technical Analysis
S&P 500
S&P 500 closed at 7,549.94, reclaiming its 200-day SMA (7,328) but still below the 21-day (7,653) and 50-day (7,676) moving averages. Nearest resistance at 7,554; nearest support at 7,357. RSI at 45.8, neutral, not yet overbought after the 2.4% rally.
Nasdaq
Nasdaq at 25,253 is barely above its 200-day SMA (25,107) but well below the 21-day (26,036) and 50-day (26,435). RSI 42.4, MACD bearish. Nearest support 24,345; resistance 26,522. The index has lost -7.7% over 30 days.
VIX
VIX at 20.11 pre-market, down from the 28+ spike on Nov 5 but still above its 200-day average (18.43). The VIX term structure remains elevated. A sustained break below 19 would signal the stress event is passing; above 22 keeps the ELEVATED regime intact.
08Cross-Market
US Treasuries
10-year yield 4.864% (+0.5bp); 2-year 4.51%; 2s10s spread +32bp (normal curve). 30-year bond 5.256%.
FX
DXY 101.76 (+0.10%). EUR/USD steady; GBP/USD ~1.3445 ahead of US CPI. USD/JPY firming.
Commodities
Crude oil $85.25/bbl (-1.84%) on demand concerns. Gold $4,082.90 (-0.77%). Copper $6.38/lb (stable).
Europe / Asia
Euro Stoxx 50 +1.07% (trading); FTSE 100 +0.47%. Nikkei 225 closed +2.87% at 60,460. Hang Seng +0.44% at 24,557. Asian markets broadly higher following the US rally.
Other
Bitcoin $74,086 (-0.98%), giving up some ground after the equity rally.
09Upcoming Calendar
Economic 2
08:30 ET
October Consumer Price Index (CPI)
Consensus not available from tool results
08:30 ET
October CPI Core (ex-food & energy)
Consensus not available from tool results
Earnings 0
None scheduled
Biotech Catalysts 4
SMMT Summit Therapeutics
BLA, Priority Review
PDUFA · Nov 14, 2026
EGFR-mutated NSCLC (ivonescimab)
First-in-class bispecific antibody targeting a $10B+ addressable lung cancer market; pivotal data already positive
CYTK Cytokinetics
sNDA
PDUFA · Nov 14, 2026
Obstructive hypertrophic cardiomyopathy (aficamten)
Franchise-defining decision for a next-gen cardiac myosin inhibitor; MAPLE-HCM data under review
BTAI BioXcel Therapeutics
sNDA
PDUFA · Nov 14, 2026
Acute agitation (IGALMI at-home use)
Expansion of approved drug into at-home setting; could dramatically expand addressable patient population
IRD Opus Genetics
sNDA Approved
FDA Approval · Nov 10, 2026
Presbyopia (RYZUMVI/phentolamine ophthalmic solution 0.75%)
FDA approval triggers milestone payment; enters competitive presbyopia treatment market
10 Stocks in Focus Quotes as of 07:44 ET

Names in focus based on expected market-moving catalysts and technical setups. Descriptive commentary only, not investment advice or a recommendation to buy or sell any security.

NVDA
Nvidia Corp.
▼DOWNSIDE Moderate PROB NEWS
$176.81 ▼ -1.04% 24h
Price at report release
Watching for continued downside as the CEO spy-scandal investigation deepens, the board launched an independent probe, the FBI is investigating, and prediction markets now price a 55% chance Huang is out before 2029. Technicals are decisively bearish (ADX 31.8, RSI 27.4 oversold, price below all major MAs) with volume running 3.9x average. Wells Fargo cut its target to $300 this morning. The $174.76 support level is the next line to watch; a break below would open a move toward the 52-week low at $164.27. RSI at 27.4 signals stretched conditions, so a reflexive bounce is possible, but the trend and catalyst flow remain firmly negative.
Resistance
$230.81+30.5% ↑
$215.27+21.8% ↑
$200.29+13.3% ↑
$190.57+7.8% ↑
▶$176.81Now
Support
$174.76−1.2% ↓
11Outlook
Today's session hinges on the October CPI print at 8:30 AM ET, a hot number could re-ignite rate-hike fears (the Fed is at 3.75–4.00% and a 25bp hike is on the table for December), while a cool print would validate the post-election recovery narrative. The NVDA scandal creates a two-speed tape: AI/semiconductor names under pressure from the CEO crisis and potential Democratic regulatory scrutiny, while cyclicals and value sectors benefit from the rotation. The VIX at 20.11 suggests elevated but not panicked conditions. A clean CPI + continued dip-buying in mega-cap tech ex-NVDA could extend yesterday's rally; a CPI miss would test the S&P 500's 7,357 support and potentially re-open last week's lows near 7,353.
Important Disclosures

This report is for informational and educational purposes only. It is not investment advice, a research report within the meaning of applicable securities regulations, or a recommendation, solicitation, or offer to buy or sell any security.

References to expected price moves, support and resistance levels, or names "in focus" are descriptive observations about market conditions and expected behaviour, not directives to take a position. SecBot is not a registered investment adviser, broker-dealer, or financial planner. Past performance does not indicate future results. Any investment decisions are solely your own and you should consult a qualified financial professional who understands your individual circumstances before acting on any information herein.

SecBot and its affiliates may hold positions in securities mentioned. Figures are sourced from third-party data providers and may contain errors; readers should independently verify before relying on any specific number.